IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Delaware

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Delaware $1,907,078.03
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Incyte Corporation Development of INCB24360 as a treatment for cancerous solid tumors. $ 244,479.25  
Incyte Corporation Development of INCB7839 as a treatment for metastatic breast cancer. $ 244,479.25  
Incyte Corporation Development of INCB18424 as a treatment for myelofibrosis $ 244,479.25  
Lake Biosciences LLC Nerve Stimulation for the Treatment of Stroke   $ 217,500.00
Lake Biosciences LLC Haptoglobin Type as a Prognostic Test for Vasospasm After Subarachnoid Hemorrhage   $ 102,500.00
OrPro Therapeutics, Inc ORP100 Inhaled Mucolytic   $ 24,000.00
QPS Holdings LLC Octreotide Phytate for Injectable Suspension (OPIS) $ 129,669.47 $ 104,738.52
QPS Holdings, LLC Leuprolide Mesylate for Injectable Suspension (LMIS) $ 81,053.15 $ 110,893.23
QPS Holdings, LLC Design, synthesis and development of highly selective matrix metalloprotease inhibitors $ 96,431.23 $ 62,375.43
Respiratory Management Technology, Inc Aerosol-Dispersion $ 6,747.22 $ 237,732.03

 

Page Last Reviewed or Updated: 09-Apr-2014